BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Anavex’s Blarcamesine Slows Cognitive Decline in Alzheimer’s Patients

  Following a controversial Rett Syndrome trial last year, Anavex Life Sciences’ blarcamesine has claimed another clinical victory—this time in an Alzheimer’s disease Phase IIb/III study.

  September 15, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Policy

  AstraZeneca’s Alexion Reaches $125M Settlement in Soliris Sales Lawsuit

  After nearly seven years, the company’s rare diseases arm Alexion has reached a settlement in an investors’ lawsuit over alleged unethical sales practices for its hemoglobinuria therapy Soliris.

  September 15, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Deals

  RayzeBio’s $311M, Neumora’s $250M IPOs Among Biotech’s Largest This Year

  The two biotech companies announced initial public offering pricing Thursday, respectively, with shares beginning trading Friday and valued at more than $560 million cumulatively.

  September 15, 2023

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  The First Annual BioTechX USA: Blending Science and Technology

  The first annual BioTechX USA, held in Santa Clara in September, bridged the communication gap by bringing together life sciences leaders in all areas of the industry.

  September 15, 2023

   · 

  4 min read

   · 

  Lori Ellis
• 

  Business

  Novartis Shareholders Approve Sandoz Spin-Off as Product Plans Increase

  The Swiss pharma’s shareholders on Friday approved spinning off the generics and biosimilars division, with plans to launch at least five additional biologic drugs.

  September 15, 2023

   · 

  2 min read

   · 

  Connor Lynch
• 

  Drug Development

  Despite Early Success, Karyopharm’s Selinexor Faces Uncertain Path to Expansion

  While achieving FDA approvals in rare cancers such as multiple myeloma and diffuse large B-cell lymphoma, Karyopharm’s cancer drug has a variety of scientific and market hurdles to clear.

  September 15, 2023

   · 

  3 min read

   · 

  Jia Jie Chen
• 

  FDA

  FDA Action Alert: ARS Pharma, Appili, Ocuphire and BrainStorm

  The FDA will finish September with three action dates and one of the year’s most highly-anticipated advisory committee meetings.

  September 15, 2023

   · 

  5 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?

  In the largest biotech Series C financing so far this year, Generate:Biomedicines raised $273 million, while Neumora and RayzeBio announced IPO pricing valued at more than $560 million combined.

  September 15, 2023

   · 

  2 min read

   · 

  Greg Slabodkin
• Policy

  SmartCardia Receives FDA Clearance for its 14-Day 7-Lead ECG Real-Time Patch and Cloud Platform

  SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform.

  September 15, 2023

   · 

  2 min read
• Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000

  Neoss Group, a leading innovator in dental implant solutions, is proud to announce the fast and easy-to-use wireless intraoral scanner, NeoScan™ 2000.

  September 15, 2023

   · 

  2 min read